CytoSorbents Corp. (CTSO) Announces Expansion of CytoSorb Dosing Study in Germany
CytoSorbents is a critical care therapeutic device company using blood purification to modulate the body's immune system. The goal of such devices is to prevent or treat multiple organ failure in life-threatening illnesses. Its unique blood purification technology is protected by 32 U.S. patents. The company announced today the expansion of its CytoSorb dosing study to eight sites in Germany. CytoSorb is the company's flagship product and has been approved in the European Union to treat life-threatening illnesses in intensive care units. CytoSorb is an extracorporeal cytokine filter designed to reduce the “cytokine storm” that can cause massive inflammation, organ…